InfuSystem Holdings, Inc. (INFU) |
| 9.07 0.01 (0.11%) 05-29 16:00 |
| Open: | 9.1 |
| High: | 9.49 |
| Low: | 9.03 |
| Volume: | 153,322 |
| Market Cap: | 183(M) |
| PE Ratio: | 24.51 |
| Exchange: | New York Stock Exchange American |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 11.00 |
| Resistance 1: | 9.87 |
| Pivot price: | 9.07 |
| Support 1: | 8.04 |
| Support 2: | 6.69 |
| 52w High: | 11.04 |
| 52w Low: | 5.38 |
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Tue, 19 May 2026
InfuSystem (INFU) EVP Funke reports RSU vesting and tax withholding - Stock Titan
Tue, 19 May 2026
InfuSystem (INFU) CFO logs RSU vesting, tax-share withholding and ends with 117,767 shares - Stock Titan
Mon, 18 May 2026
InfuSystem Announces $20 Million Stock Repurchase Program - Business Wire
Thu, 14 May 2026
InfuSystem (NYSE: INFU) elects Beverly Huss as new board chair - Stock Titan
Thu, 14 May 2026
InfuSystem (INFU) director John Sviokla awarded 24,890 stock options at $8.37 strike - Stock Titan
Thu, 14 May 2026
InfuSystem (INFU) director Shuda awarded 24,890 options, reports direct and indirect holdings - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |